L-Arginine, Suatu Peluang Neuroproteksi terhadap Pasien Preeklampsia yang mendapat Problem Neurologis

Niken Asri Utami, Zafrullah Kany Jasa

Abstract


Preeklampsia mengakibatkan komplikasi pada 3–5% dari seluruh kehamilan. Dihubungkan dengan persalinan prematur, solusio plasenta dan lahir mati serta komplikasi stroke iskemik, stroke perdarahan, edema serebri serta kejang. Pasien dengan preeklampsia menunjukkan peningkatan tekanan perfusi otak pada arteri serebri media, anterior dan posterior, disertai perubahan indeks resistensi arteri serebri. Insiden komplikasi serebrovaskuler menyumbangkan 40% kematian maternal. Terjadi gangguan autoregulasi dan pembentukan edema. Gangguan autoregulasi dihubungkan dengan penurunan resistensi serebrovaskuler, hipoperfusi otak, disrupsi sawar darah otak serta edema vasogenik. Terjadi peningkatan sitokin pro inflamasi dan aktivasi sel-sel glia otak. L-Arginine adalah kompleks asam amino yang memiliki bentuk aktif dalam bentuk L-Arginine (2 – amino – 5 guanidino – pentanoic acid). Substrat L-Arginine untuk membentuk nitric oxide (NO) memiliki peran penting pada pembuluh darah. Pemberian L-Arginine secara intravena 5 menit setelah terjadinya cedera mengembalikan nilai aliran darah otak, memperbaiki sirkulasi serebral serta secara signifikan mereduksi volume otak yang memar. Efek neuroprotektif yang sama telah diamati terjadi  pada percobaan lain model cedera otak traumatik dan pada beberapa model iskemia serebri dengan pemberian dini L-Arginine. L-Arginine dapat menjadi agen neuroproteksi potensial yang sangat menarik untuk memperbaiki serebral setelah cedera otak.

 

L-Arginine, a Neuroprotection Chance for Preeclampsia Patients
with Neurological Problem

Abstract

Preeclampsia complicates 3 – 5% of all pregnancies. Preeclampsia is associated with premature delivery, placental abruption and stillbirth and can lead to complications, such as ischemic stroke, hemorrhagic stroke, cerebral edema and seizures. Patients with preeclampsia shows an increase in cerebral perfussion pressure (CPP) in anterior, middle and posterior cerebral arteries, with accompanying changes in cerebral artery resistance indices. The incident of cerebrovascular complications contributes to 40% of maternal death. Disturbance in autoregulation and subsequent edema formation. Disturbance in CBF autoregulation also associated with decrease in cerebrovascular resistance, brain hypoperfusion, blood brain barrier (BBB) disruption and vasogenic edema. There is also an increase in release of pro inflammatory cytokines and glial cells activation. L- Arginine is an amino acid complex, with active form in L-Arginine (2 – amino – 5 guanidino – pentanoic acid) found in vegetable and animal origin proteins, such as dairy, meat and most of all in fish and nuts. L-Arginine substrate creating Nitric Oxide (NO) plays important role in vascular. Intravenous administration of L-Arginine 5 minutes after brain injury restores cerebral blood flow (CBF) level, improves cerebral circulation and significantly reduces the contused brain volume. The same neuroprotective effect on another traumatic brain injury (TBI) model was observed and also found in cerebral ischaemia model with early administration of L-Arginine. L-Arginine can be a potential neuroprotective agent to improve of cerebral circulation after brain injury


Keywords


neuroprotection; L-Arginine; preeclampsia; L-Arginine; Preeklampsia; Neuroproteksi

Full Text:

PDF

References


Mirkovic L, Nejkovic L, Micic J. A New Pathophysiological concept and new classification of preeclampsia. University of Belgrade Serbia 2018; 75(1): 83 – 94.

McDermott M, Miller EC, Rundek T, Hurn PD. Preeclampsia association with posterior reversible encephalopathy syndorme and stroke. Stroke. 2017; 49: 524 – 30.

Young BC., Levine RJ., Karumachi SA. 2010. Pathogenesis of preeclampsia. Annual Review Pathological Mechanism Diseases. 2010; 5 : 173 – 92.

Reutens DC, McHugh MD, Toussaint PJ. Evans AC, Gjedde A, Meyer E, Stewart DJ. L-Arginine infusion increases basal but not activated blood flow in umans. Journal of Cerebral Blood Flow and Metabolism. 1997: 17:309 – 15.

Hammer ES M.D, Cipolla JM. Cerebrovascular dysfunction in preeclamptic pregnancies. Current Hypertension Report. 2015; 17(8): 64.

Logue OC, George EM, Gene L, Bidwell I. Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia. Clinical Science 2016 ; 130(16) : 1417–34

Nelander M. Preeclampsia and the brain.Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine Acta Universita Tis Upsaliensis Uppsala: 2018.

Johnson AC, Nagle KJ, Tremble SM, Cipolla MJ. Mechanisms of seizure during Pregnancy and Preeclampsia. Graduate College Dissertations and Theses. University of Vermont. 2015. Paper 336.

Cherian L, Chacko G, Goodman C, Robertson CS. Neuroprotective effects of L- Arginine administration after cortical impact injury in rats: dose response and time window. The Journal of Pharmacology and Experimental Therapeutics, 2002; 304: 617–23.

Hosomi N. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism. 2005; 25(8):959–67.

Patigaroo AF. Tumor necrosis factor alpha in preeclampsia. International Journal of Basic and Applied Physiology. 2013; 2(1) : 224-7

Ebadi B. The effect of L-Arginine on the brain tissue of stressed rats. Basics and Clinical Neuroscience 2009; 1(2): 33-6

Jaramillo PL, Arenas WD, Garcia RG, Lopez M. The role of the L-arginine-nitric oxide pathway in preeclampsia. Therapeutic Advances in Cardiovascular Disease. 2008. 2(4) : 261–75

Kusumawati R, Jusup R, Sulastomo H. L-arginine decreases hypertensionin preeclampsia model of rats. Journal of Hypertension, 2015; 33: 28.

Hegde CV. The Use of L-Arginine in the management of pre-eclampsia and intrauterine growth restriction. The Journal of Obstetrics and Gynecology of India. 2012; 62(1):1–2.

Garry PS, Ezra M, Rowland MJ, Westbrook J, Pattinson KT. The role of the nitric oxide pathway in brain injury and its treatment from bench to bedside. Experimental Neurology. 2015; 263: 235–43

Oda N. Cerebral blood flow regulation by nitric oxide: recent advances the American Society for Pharmacology and Experimental Therapeutics Pharmacol Rev, 2009, 61(1): 62-97.

Armengou A, Hurtado O, Leira R, Obon M, Pascual C, Moro MA, Lizosoain C, Castillo J, Davalos A. L-Arginine levels in blood as a marker of nitric oxide–mediated brain damage in acute stroke: a clinical and experimental study. Journal of Cerebral Blood Flow & Metabolism. 2003; 23: 978–84.

Kondoh H. Lysine and arginine reduce the effects of cerebral ischemic insults and inhibit glutamate-induced neuronal activity in rats integrative Neuroscience June 2010. Volume 4 (18):1–10.

Ando H, Nara Y, Kosaka Y, Arai M, Okamoto H. Neuroprotective effect of nitrite-derived NO in brain injury mediated through the NOS-independent but not the GC/COX/xanthine oxidase/PGIS-dependent pathways Kitasato Medical Journal 2016. 46: 67–72.




DOI: https://doi.org/10.24244/jni.v8i2.224

Refbacks

  • There are currently no refbacks.


                                    

 

JNI is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License